Exemestane(Aromasin) Raws Powder CAS：107868-30-4

↵

Exemestane (Aromasin) is a drug commonly used to treat breast cancer, especially for patients with estrogen receptor-positive (ER+) breast cancer. It belongs to the **Aromatase Inhibitor (AI)**, which inhibits the activity of aromatase and reduces the synthesis of estrogen, thereby inhibiting the growth and spread of breast cancer cells.

### Physical and chemical properties:

- **Chemical name**: Exemestane

- **Molecular formula**: C20H24O2

- **Molecular weight**: 296.41 g/mol

- **Chemical structure**: Exemestane is a synthetic steroid compound with a chemical structure similar to that of steroid hormones. It is an irreversible aromatase inhibitor. It prevents aromatase from converting androgens into estrogens by binding to aromatase.

- **Appearance**: Exemestane raw material powder is usually white or off-white crystalline powder.

- **Solubility**: Exemestane is insoluble in water, but soluble in organic solvents such as ethanol and dichloromethane.

### Pharmacological action:

Exemestane's mechanism of action is to reduce the level of estrogen in the body by irreversibly inhibiting aromatase (CYP19). Estrogen plays a role in promoting tumor growth in some types of breast cancer (especially estrogen receptor-positive breast cancer), so by reducing estrogen levels, the progression of cancer can be slowed or inhibited.

- **Aromatase action**: Aromatase is the key enzyme that catalyzes the conversion of androgens into estrogen. Exemestane binds to aromatase, changes its structure, causes its activity to be lost, and thus reduces the synthesis of estrogen.

### Clinical use:

- **Breast cancer**: Exemestane is mainly used to treat postmenopausal women with estrogen receptor-positive breast cancer, especially as an adjuvant therapy after surgery, radiotherapy or chemotherapy, or for the treatment of metastatic breast cancer.

- **Prevention**: Exemestane is also used to prevent breast cancer in high-risk women, but is usually used as an adjuvant therapy after those who have received other treatments (e.g., tamoxifen).

### Dosage:

The usual dose of Exemestane is **25 mg once daily**, usually taken after meals. The duration of the treatment regimen is usually **5 years**, especially for adjuvant treatment of patients with estrogen receptor-positive breast cancer. In some special cases, the treatment period may be adjusted, and the specific dose and cycle should be adjusted according to the doctor's guidance.

### Half-life and pharmacokinetics:

- **Half-life**: Exemestane has a half-life of approximately **24 hours**, which means that it takes about 24 hours for the concentration of the drug in the body to be reduced by half. Due to its long half-life, Exemestane can be taken once a day.

- **Absorption and distribution**: Exemestane is rapidly absorbed after oral administration and has good bioavailability in the gastrointestinal tract. It is widely distributed in the body, can cross the blood-brain barrier, and has a certain liver metabolism.

- **Metabolism and excretion**: Exemestane is mainly metabolized by the liver, and the metabolites are excreted through urine. Due to its complex metabolism in the body, the metabolism of some people may be different.

### Pharmacodynamics and treatment cycle:

- **Action cycle**: The treatment cycle of Exemestane is usually determined according to the specific situation of the patient. For breast cancer patients, it is usually used continuously for 5 years, especially in postmenopausal women.

- **Therapeutic effect**: The therapeutic effect of Exemestane has shown good efficacy in clinical trials, especially when used in combination with other therapeutic drugs (such as tamoxifen). It has been shown to reduce the risk of breast cancer recurrence and has shown significant clinical effects in some patients with metastatic breast cancer.

### Side effects:

Although Exemestane is effective for breast cancer patients, it may also cause some side effects. Common side effects include:

- **Menopausal symptoms**: such as hot flashes, sweating, and vaginal dryness.

- **Joint pain or muscle pain**: Exemestane may cause joint discomfort, and some patients experience joint inflammation or pain.

- **Bone density reduction**: Long-term use of Exemestane may increase the risk of osteoporosis, so bone density monitoring is sometimes required.

- **Gastrointestinal discomfort**: such as nausea, vomiting, or indigestion.

- **Other**: Headache, fatigue, insomnia, etc.

### Precautions and contraindications:

- **Hepatic insufficiency**: For patients with liver insufficiency, Exemestane should be used with caution and the dosage needs to be adjusted according to the doctor's guidance.

- **Pregnant and lactating women**: Exemestane is contraindicated for pregnant and lactating women because it may have adverse effects on the fetus.

- **Drug interactions**: Exemestane may interact with certain drugs (such as strong CYP3A4 inhibitors), resulting in increased or decreased drug concentrations.

### Summary:

Exemestane (Aromasin) is an effective aromatase inhibitor used to treat estrogen receptor-positive breast cancer, especially in postmenopausal women. It reduces the synthesis of estrogen in the body by inhibiting aromatase, thereby inhibiting tumor growth. Although its efficacy is relatively significant, it also has certain side effects and needs to be used under the guidance of a doctor.

Exemestane (Aromasin) is a drug used to treat breast cancer, especially for patients with estrogen receptor-positive breast cancer who have undergone surgery or frequently use drugs such as tamoxifen. Its main function is to inhibit the synthesis of estrogen in the body.

### Applicable population

Exemestane is mainly used for the following populations:

1. **Estrogen receptor-positive breast cancer patients**: Especially those women who have undergone surgery, radiotherapy and chemotherapy, and continue to develop breast cancer during or after treatment.

2. **Postmenopausal women**: Exemestane is a selective aromatase inhibitor (AI) that reduces the synthesis of estrogen in the body by inhibiting the activity of aromatase. Because postmenopausal women mainly produce estrogen through peripheral tissues, and Exemestane works through this mechanism.

3. **Adjuvant therapy for breast cancer**: Exemestane can also be used as an adjuvant therapy drug to reduce the risk of recurrence of breast cancer, usually after surgery and radiotherapy and chemotherapy.

4. **Resistant patients**: Exemestane may be effective for those breast cancer patients who are resistant to tamoxifen.

### How it works

Exemestane belongs to the aromatase inhibitor class of drugs, which reduces the synthesis of estrogen in the body by inhibiting the activity of aromatase. Aromatase is a key enzyme responsible for converting androgens into estrogen. Estrogen can promote the growth of some types of breast cancer cells. By inhibiting aromatase, Exemestane effectively reduces the level of estrogen, thereby slowing or stopping the growth of estrogen receptor-positive breast cancer cells.

### Dosage and Administration

The usage and dosage of Exemestane are usually determined by the doctor based on the specific situation of the patient. The following is the general usage:

1. **Regular dose**: Adult patients usually take 25 mg of Exemestane orally per day, usually after meals.

2. **Treatment cycle**: Treatment usually needs to be maintained for at least 5 years to help reduce the risk of breast cancer recurrence. The specific course of treatment should be adjusted according to the doctor's advice.

3. **Adjust the dose**: If the patient experiences side effects, the dose may need to be adjusted or the drug may need to be discontinued. Patients with abnormal liver and kidney function may need to pay special attention to dose adjustments.

4. **Time of use**: Exemestane is usually used as part of long-term treatment and can be used after surgery or other treatments for breast cancer.

### Precautions

- **Side effects**: Exemestane may cause some side effects, such as hot flashes, joint pain, fatigue, and decreased bone density.

- **Bone density**: Long-term use of Exemestane may lead to decreased bone density, so patients may need to monitor bone density regularly, especially postmenopausal women.

- **Liver and kidney function**: Patients with impaired liver and kidney function need to be particularly careful when using it, and may need to adjust the dose or avoid use.

- **Pregnancy and lactation**: Exemestane is not recommended for pregnant or lactating women.

### Summary

Exemestane (Aromasin) is a drug used to treat estrogen receptor-positive breast cancer. It mainly reduces the synthesis of estrogen in the body by inhibiting aromatase, thereby slowing the progression of breast cancer. It is generally suitable for postmenopausal women, especially when other treatments have failed. Usage is usually 25 mg orally per day, with a long treatment cycle, and side effects may include hot flashes, joint pain, etc.

Exemestane (trade name Aromasin) is a drug that belongs to the aromatase inhibitor class and is commonly used to treat hormone receptor-positive breast cancer, especially in postmenopausal women. It works by inhibiting the activity of the aromatase enzyme to reduce the level of estrogen in the body, thereby inhibiting the growth of cancer cells promoted by estrogen. Exemestane is usually sold in the form of raw powder for use in pharmaceuticals or self-prepared drugs.

Here are some of the main benefits and mechanisms of action of Exemestane:

### 1. **Treatment of hormone receptor-positive breast cancer**

Exemestane is mainly used to treat **hormone receptor-positive breast cancer**, especially in postmenopausal women. Hormone receptor-positive breast cancer refers to tumor cells that have estrogen receptors on their surface, and the growth of these cancer cells is stimulated by estrogen. Exemestane significantly reduces the level of estrogen in the body by inhibiting the action of aromatase (an enzyme that converts androgens to estrogen), thereby slowing or inhibiting the growth of cancer cells.

### 2. **Reduces the level of estrogen in the body**

Exemestane works by specifically inhibiting the aromatase enzyme, preventing androgens from being converted to estrogen, thereby significantly reducing the level of estrogen in the body. Estrogen is a growth stimulator for many types of cancer, especially breast cancer. Exemestane can effectively reduce estrogen levels in the body, thereby reducing the risk of recurrence of estrogen-dependent breast cancer.

### 3. **Preventing breast cancer recurrence**

Another major role of exemestane in breast cancer treatment is **preventing breast cancer recurrence**. Especially after early breast cancer treatment, exemestane as an adjuvant therapy can help reduce the risk of cancer recurrence. For patients who have already undergone surgery, radiotherapy or chemotherapy, exemestane can help further reduce the chance of cancer recurrence.

### 4. **Advantages over other aromatase inhibitors**

Exemestane, as a **non-steroidal aromatase inhibitor**, has a stronger inhibitory effect than other aromatase inhibitors such as Letrozole and Anastrozole. Exemestane forms a covalent bond with aromatase, making its activity lastingly inhibiting the synthesis of estrogen. Other drugs, such as Letrozole, work mainly through competitive inhibition, so exemestane may provide more stable and long-lasting treatment in some cases.

### 5. **Long-term effects on hormone levels in the body**

Due to Exemestane's effectiveness in reducing estrogen levels in the body, it is not only suitable for breast cancer patients, but may also have an impact on **improving male hormone imbalance** (such as male health problems related to high estrogen levels). In some cases, Exemestane is used for **hormone level management** in men, such as reducing the impact of excess estrogen in the body on men's health, or helping men reduce side effects caused by estrogen, such as breast hypertrophy.

### 6. **Improving other diseases related to estrogen**

Due to Exemestane's effective reduction of estrogen levels in the body, it may have benefits for some **diseases related to excess estrogen**. For example, Exemestane may have some effect in reducing the symptoms of **endometriosis** caused by high estrogen. In addition, Exemestane may also be studied for slowing the progression of estrogen-dependent cancers such as **ovarian cancer**.

### 7. **Slowing or inhibiting certain types of hormone-dependent cancer**

Exemestane may also potentially be used as an adjunct to the treatment of other types of **hormone-dependent cancer**, particularly estrogen-dependent prostate cancer and other endocrine cancers. By suppressing estrogen levels in the body, exemestane may help reduce the growth and spread of cancer cells.

### 8. **Possible weight management effects**

Although exemestane's primary role is in the treatment of breast cancer, some studies suggest that aromatase inhibitors such as exemestane may help with **weight management** in some individuals. This is because by reducing estrogen levels, exemestane may help reduce hormonal signals for fat storage, aiding weight management.

### 9. **Side effects and precautions for use**

Although exemestane is highly effective in treating conditions such as breast cancer, its use may also be accompanied by some side effects. Common side effects include:

- **Decrease in bone density**: Estrogen plays a protective role in bone health, and lowering estrogen levels may increase the risk of fractures.

- **Hot flashes**: Some women may experience menopausal symptoms such as hot flashes while using exemestane.

- **Joint pain**: Aromatase inhibitors are often associated with symptoms such as joint pain.

- **Fatigue, headache**: These are common side effects that may affect patients' daily activities.

- **Cardiovascular health risks**: Studies have shown that long-term use of Exemestane may have a certain impact on the cardiovascular system.

### Summary:

Exemestane, as an aromatase inhibitor, has significant clinical benefits in fighting breast cancer, regulating estrogen levels, improving the survival rate of breast cancer patients and reducing recurrence. Its mechanism of action is to inhibit the synthesis of estrogen in the body, which is especially important for patients with hormone receptor-positive breast cancer. Although it has obvious benefits in treatment, it may bring some side effects, so it needs to be used under the guidance of a doctor.

WhatsApp/Telegram:+852 6749 2648

Gmail:lucasraws207@gmail.com

Skype：live:.cid.8f21dc7fc6621ba7

Hot Tags: exemestane(aromasin) raws powder cas：107868-30-4, China exemestane(aromasin) raws powder cas：107868-30-4 manufacturers, suppliers, factory, Testosterone Enanthate CAS 315 37 7, Testosterone isocaproate increases muscle mass and improves strength, Testosterone Phenylpropionate CAS 1255 49 8, Testosterone Propionate CAS 57 85 2, Testosterone Decanoate, Testosterone Sustanon and SUS250 have long lasting effects